Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

News Daily News

Knowing Comorbidities, Medication Use May Save Lives in COVID-19

Michael O'Riordan

December 15, 2020

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Daily News

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Michael O'Riordan

August 14, 2020

News Daily News

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Michael O'Riordan

July 13, 2020

News Daily News

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

L.A. McKeown

June 25, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

L.A. McKeown

April 01, 2020

Presentation ACC 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presenter: William Hiatt

March 29, 2020

Advertisement

Knowing Comorbidities, Medication Use May Save Lives in COVID-19

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Study Affirms Thrombotic Risk in COVID-19

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Could Statins Curb Fatal or Severe COVID-19? Some Clues

Heart, Kidneys, Brain, and More: COVID-19’s Wide-ranging Effects

Multiorgan Clotting in COVID-19 Hints at Platelets’ Role in Inflammatory Response

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content